CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 21 filers reported holding CANDEL THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,668 | -26.2% | 27,600 | 0.0% | 0.00% | – |
| Q2 2023 | $34,776 | -8.0% | 27,600 | 0.0% | 0.00% | – |
| Q1 2023 | $37,812 | -61.7% | 27,600 | -50.0% | 0.00% | – |
| Q4 2022 | $98,808 | +13.6% | 55,200 | +100.0% | 0.00% | – |
| Q3 2022 | $87,000 | -2.2% | 27,600 | 0.0% | 0.00% | – |
| Q2 2022 | $89,000 | -36.4% | 27,600 | 0.0% | 0.00% | – |
| Q1 2022 | $140,000 | -32.7% | 27,600 | +3.8% | 0.00% | – |
| Q4 2021 | $208,000 | -27.8% | 26,600 | 0.0% | 0.00% | – |
| Q3 2021 | $288,000 | – | 26,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 1,935,215 | $3,464,035 | 1.88% |
| Sands Capital Ventures, LLC | 811,737 | $1,453 | 0.40% |
| Empirical Asset Management, LLC | 12,000 | $21,480 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,700 | $237,533 | 0.01% |
| Ergoteles LLC | 26,114 | $46,744 | 0.00% |
| FRANKLIN RESOURCES INC | 1,125,000 | $2,013,750 | 0.00% |
| Tower Research Capital LLC (TRC) | 7,214 | $13 | 0.00% |
| WELLS FARGO & COMPANY/MN | 98 | $175 | 0.00% |
| NORTHERN TRUST CORP | 14,483 | $25,925 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |